BSG and neoplasm: Immunoprecipitation of VEGFR-2 followed by immunoblotting with pVEGFR-2 antibody have shown that EMMPRIN knockdown by siRNA decreased VEGFR-2 phosphorylation mediated by VEGF, in both endothelial and tumor cells (Figure 5A).